Clinical Trial Update: Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating safety and efficacy of doxorubicin-eluting microspheres delivered by transarterial embolization for hepatocellul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: University of British Columbia | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED